Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$38.10 0.41 (1.09%)
2/9/2010 4:04 PM

Watson Pharmaceuticals, Inc. (WPI)

CAPS Rating:
***

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating WPI

Add Stock to Watchlist

What the Community Thinks

Total Members

147 Outperforms
17 Underperforms
 

All-Stars

51 Outperforms
5 Underperforms
 

Wall Street

10 Outperforms
2 Underperforms
 

Members bullish on WPI are also bullish on:

Members bearish on WPI are also bearish on:

Ticker Tags

S&P 500 (499), Mid Cap (610), Defensive (1457), Healthcare (711), Pharmaceuticals (149)
Suggest a tag

Watson Pharmaceuticals, Inc. At A Glance

Current Price: $38.10
Last Trade Time: 2/9/2010 4:04 PM
Open: $37.95
Previous Close: $37.69
Daily Range: $37.73 - $38.38
52-Week Range: $25.31 - $42.50
Volume: 860,159
Market Cap: $4.04B
P/E Ratio: 17.53
Compare Our Special Broker Offers!

Stock Trends

WPI VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

4

Watson Pharmaceuticals, Inc. (WPI)

Avatar stockblog (68.49) Submitted: 9/28/08 8:10 PM

The generic drug industry is rapidly consolidating amidst a flurry of recent M&A activity -- including the following buyout offers:

Industry leader Teva Pharma (TEVA): buyout bids for Barr (BRL) ($7.5B) & Bentley Pharma (BNT) ($350M)
Sanofi-Aventis (SNY): a $2B bid for Czech-based Zentiva (which ha...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 20 :   1 2 3 4 Next »

Recs

0

 (WPI)

Avatar JDKeene (88.86) Submitted: 8/12/09 1:01 PM : Outperform Start Price: $34.88 WPI Score: 2.59

Ford Strong Buy, S&P (4 or 3 stars), Member of S&P 500

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (WPI)

Avatar F111Driver (82.74) Submitted: 8/05/09 7:52 AM : Outperform Start Price: $34.84 WPI Score: -1.16

WPI has a portfolio of drugs of which more than 80% are generic...with health care reform (i.e. cost cutting) looming, they are well positioned to reap the benefits. The company just launched a generic alternative to Ferrlecit (an iron therapy replacement for dialysis patients) which will spoil profits for companies selling high priced brand names (see my AMAG pick). With Paul Bisaro (former CEO of Barr Pharmaceuticals) at the helm, this company is a good bet to outperform its peers.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (WPI)

Avatar Doctomme (31.44) Submitted: 7/14/09 2:28 AM : Outperform Start Price: $32.97 WPI Score: -0.20

Manufactor of Norco a popular alternative to Vicodin used by many hospitals, following FDA's fear of acetaminophen. (Note, most Tylenol type Overdoses are intentional)

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Recs

0

 (WPI)

Avatar Keithkos1 (24.64) Submitted: 4/25/09 10:20 PM : Outperform Start Price: $32.00 WPI Score: -7.39

big player, sound strategy

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 20 :   1 2 3 4 Next »

Wall Street

Results 1 - 12 of 12  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackSunTrustRH 87.33 12/10/09 Outperform NS $37.99+0.29%-3.14%+3.43
TrackRBCCapMkts 86.33 04/23/09 Outperform NS $29.29+30.08%+27.89%+2.19
TrackStanfordRes 85.54 01/22/09 Outperform NS $24.33+56.60%+32.39%+24.20
TrackCreditSuiss 93.62 11/06/08 Underperform NS $24.40+56.15%+16.42%-39.73
TrackWellsFargo 80.02 09/22/08 Outperform NS $28.98+31.47%-11.71%+43.18
TrackJimCramer < 20 09/04/08 Underperform 3W $30.26+25.91%-10.80%-36.71
TrackSoros 82.58 03/31/08 Outperform NS $29.32+29.95%-15.75%+45.69 Toggle the visibility of 60-Second Pitch and replies
TrackWRHambrecht 64.18 02/19/08 Outperform NS $28.52+33.59%-18.25%+51.84
TrackEdwardOwens 98.91 09/30/07 Outperform NS $32.40+17.59%-26.38%+43.97 Toggle the visibility of 60-Second Pitch and replies
TrackRothCapital 80.39 09/28/07 Outperform NS $33.00+15.45%-26.51%+41.96
TrackUBS 87.99 05/02/07 Outperform NS $30.01+26.96%-23.87%+50.83
TrackFTNEquityCa 65.55 10/17/06 Outperform NS $26.56+43.45%-16.53%+59.98

Results 1 - 12 of 12  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD02 781ms